Australia markets closed

Bioventus Inc. (BVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.9600-0.1100 (-2.70%)
At close: 04:00PM EDT
3.9600 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.0700
Open4.0300
Bid3.9400 x 200
Ask3.9700 x 200
Day's range3.9000 - 4.1650
52-week range0.8600 - 6.0800
Volume113,132
Avg. volume142,375
Market cap250.98M
Beta (5Y monthly)0.50
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

    DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2024 before the market opens on Tuesday, May 7, 2024. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-8

  • GlobeNewswire

    Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

    Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3%Appointed Rob Claypoole as President and Chief Executive Officer, bringing more than 20 years of leadership experience in the global medical device industryProvides full-year 2024 financial guidance reflecting enhanced revenue growth and improved execution DURHAM, N.C., March 12, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today ann

  • GlobeNewswire

    Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

    DURHAM, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2024 before the market opens on Tuesday, March 12, 2024. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial